Metropolitan Life Insurance Company (MetLife)’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,222
Closed -$43.3K 1681
2024
Q1
$43.3K Hold
5,222
﹤0.01% 1481
2023
Q4
$57.5K Hold
5,222
﹤0.01% 1372
2023
Q3
$43.9K Buy
5,222
+384
+8% +$3.23K ﹤0.01% 1481
2023
Q2
$60.8K Hold
4,838
﹤0.01% 1312
2023
Q1
$79.7K Sell
4,838
-426
-8% -$7.02K ﹤0.01% 1122
2022
Q4
$78.6K Buy
5,264
+706
+15% +$10.5K ﹤0.01% 1202
2022
Q3
$102K Hold
4,558
﹤0.01% 1007
2022
Q2
$76.3K Hold
4,558
﹤0.01% 1224
2022
Q1
$136K Sell
4,558
-13,536
-75% -$405K ﹤0.01% 1009
2021
Q4
$556K Buy
18,094
+1,810
+11% +$55.6K 0.01% 1357
2021
Q3
$513K Hold
16,284
0.01% 1444
2021
Q2
$596K Buy
16,284
+3,453
+27% +$126K 0.01% 1403
2021
Q1
$444K Buy
12,831
+3,406
+36% +$118K 0.01% 1499
2020
Q4
$392K Hold
9,425
0.01% 1521
2020
Q3
$401K Buy
+9,425
New +$401K 0.01% 1362